IONIS PHARMACEUT reported $2.16B in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agios Pharmaceuticals AGIO:US $ 1305.29M 397.28M
Alnylam Pharmaceuticals ALNY:US $ 2675.36M 49.8M
Arena Pharmaceuticals ARNA:US $ 790.92M 199.52M
Arrowhead Research ARWR:US $ 384.6M 141.36M
Astellas Pharma 4503:JP Y 876454M 7739M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Dicerna Pharmaceuticals DRNA:US $ 589M 27.49M
Esperion Therapeutics ESPR:US $ 170.67M 104.51M
Exelixis EXEL:US $ 1662.03M 68.78M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Halozyme Therapeutics HALO:US $ 1017.3M 17.55M
Mirati Therapeutics MRTX:US $ 1171.89M 106.2M
Moderna Inc MRNA:US 13.42B 2.46B
Nektar Therapeutics NKTR:US $ 986.14M 70.01M
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Novartis NOVN:VX 26.25B 2.45B
Omeros OMER:US $ 91.35M 21.05M
Ptc Therapeutics PTCT:US $ 1011.14M 55.09M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Sarepta Therapeutics SRPT:US $ 2185.31M 79.91M
Ultragenyx Pharmaceutical RARE:US $ 846.88M 102.61M
Vertex Pharmaceuticals VRTX:US $ 8852.54M 395.03M